About the Book

The substantial changes in this book reflect the many significant advances that have been made since publication of the second edition only three years ago. It therefore provides a greater understanding of the specific biological factors affecting pharmacokinetic processes of drug toxicity, and the practical uses of pharmacokinetic knowledge. The book remains a highly readable and informative account of the subject which greatly help students and postgraduates of pharmacy and pharmacology to develop a rational approach to the investigation and application of drugs.

Salient Features

· Emphasis is given to recent studies on age, genetics and disease.

· Rearranged the book with new material and the size has grown accordingly.

Review

Contents

About the Author

Professor Stephen Curry has over 40 years experience of academia and of the pharmaceutical industry.  He has directed departments, projects and programs in London and Florida, and in Rochester NY, where he is currently Adjunct Professor of Pharmacology and Physiology at the University of Rochester. He is President of his own consulting company, Stephen H. Curry Consulting. He was a founding Partner of PharmaNova, a Rochester company dedicated to the discovery of novel non-hormonal treatments for menopausal symptoms, using existing neurologically-active drugs, and was also at one time President of Nanolution. He holds the Doctor of Science Degree from the Faculty of Medicine of the University of London, and an honorary D.Sc. from DeMontfort University, and is a Fellow of the Royal Pharmaceutical Society of Great Britain.